| Literature DB >> 10566276 |
E Andrès1, C Kuhnert, A E Perrin, G Averous, A Ruellan, B Goichot, J L Schlienger.
Abstract
BACKGROUND: BCG therapy is an effective treatment for superficial bladder carcinoma. Exceptionally, systemic disorders including hypersensitivity reactions or infections may occur. CASE REPORT: A 70-year-old man developed septicemia with bone marrow granulomatosis with a favorable course after intravesicle administration of bacillus Calmette-Guérin for bladder carcinoma. DISCUSSION: High grade fever, septicemia, hepatitis or pulmonary granulomatosis as well as bone marrow involvement are reported in less than 1% of all cases of BCG therapy. The pathogenic mechanisms are complex. Anti-tuberculous drugs are generally given.Entities:
Mesh:
Year: 1999 PMID: 10566276
Source DB: PubMed Journal: Presse Med ISSN: 0755-4982 Impact factor: 1.228